Brian Paul Ceresa, Ph.D. CURRICULUM VITAE - OU Medicine

23. August 2003: American Association for Cancer Research, Dinneen, J.L. and Ceresa, B.P.,
Expression of dominant negative rab7(N125I) slows EGFR endocytic trafficking and enhances
EGFR–mediated cell proliferation. (Poster)
24. September 2002: DOD Era of Hope, Dinneen, J.L. and Ceresa, B.P., Dominant negative
rab5(S34N) inhibits EGFR endocytic trafficking to the early endosome. (Poster)
25. June 2002: FASEB Summer Research Conference: Receptors and Signal Transduction Dinneen,
J.L. and Ceresa, B.P., Dominant negative rab5(S34N) inhibits EGFR endocytic trafficking to the
early endosome. (Poster).
26. March 2001: American Association for Cancer Research, Ceresa, B. P. and Schmid, S. L.,
Expression of rab5(Q79L) Enlarged Endosomes Does Not Alter Epidermal Growth Factor
Receptor Endocytic Trafficking (Poster).
c. Invited Seminars:
1. May 17, 2011 – University of Vermont, Department of Pharmacology “Optimizing Epidermal
Growth Factor Receptor Activity by Modulating Its Endocytic Trafficking”
2. March 25, 2011 – Harrison School of Pharmacy, Auburn University “Optimizing Epidermal
Growth Factor Receptor Activity by Modulating Its Endocytic Trafficking"
3. January 22, 2010 – Oklahoma Christian University “Manipulating the Activity of the Epidermal
Growth Factor Receptor To Promote Corneal Epithelial Wound Healing”
4. February 18, 2009 – University of Nebraska, Lincoln – “HPV16 E5 Mediated Cell:Cell Fusion - A
New Model for Inducing Carcinogenesis"
5. April 20, 2006 – Geisinger Clinic, Danville, PA – “Rab7 Regulation of EGFR Endocytic
Trafficking”
6. Oct 15, 2004 – Oklahoma State University, Center for Health Sciences “Rab5 Regulation of EGFR
Endocytic Trafficking”
7. February 4, 2004 – Oklahoma Christian University “Regulation of Endocytic Trafficking of the
EGFR”
8. July 24, 2003 – Oklahoma State University “Rab5 as a regulator of Endocytic Trafficking”
Local Seminars:
1. September 2011: Dean McGee Eye Institute Dedication
“Re-directing Traffic: A New Way to Restore the Corneal Epithelium”
2. January 2008: Cell Biology and Biochemistry Seminar Series
“HPV16 E5 induces polyploidy by Cell Fusion”
2. May 2006: HPV Research Month at the OU Cancer Institute
“Designing a Tissue Culture Model to Study the Effects of HPV16 E5 on EGFR Trafficking and
Signaling”
3. January 2001: Oklahoma Center for Neuroscience Hot Topics
“Cell Signaling: 2001 and Beyond”
4. January 2001: Molecular Pathology Conference
“Determinants of Gene Expression II: Cell Signaling”
d. Ad Hoc Reviewer
Journals:
European Molecular Biology Organization (EMBO) Journal (2001–Present)
EMBO Reports (2001-Present)
Experimental Cell Research (2004-Present)
Histology and Histopathology-Cellular and Molecular Biology (2006)
Molecular Biology of the Cell (2003 – Present)
Molecular and Cellular Biology (2003-Present)
Traffic (2006-Present)
Journal of Cell Science (2005-Present)
Investigative Ophthalmology & Visual Science (2010)
_____________________________________________________________________________________
Curriculum Vita for Brian P. Ceresa, PhD, Dept of Cell Biology Page - 6